Skip to main content
Nature Communications logoLink to Nature Communications
. 2023 Sep 5;14:5404. doi: 10.1038/s41467-023-41255-0

Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer

Dzana Dervovic 1, Ahmad A Malik 1,2, Edward L Y Chen 1, Masahiro Narimatsu 1, Nina Adler 3, Somaieh Afiuni-Zadeh 1, Dagmar Krenbek 4, Sebastien Martinez 1, Ricky Tsai 1, Jonathan Boucher 5, Jacob M Berman 1, Katie Teng 1,2, Arshad Ayyaz 1,6, YiQing Lü 1,2, Geraldine Mbamalu 1, Sampath K Loganathan 1,7, Jongbok Lee 8, Li Zhang 8,9, Cynthia Guidos 10, Jeffrey Wrana 1,2, Arschang Valipour 11, Philippe P Roux 5,12, Jüri Reimand 2,3, Hartland W Jackson 1,2, Daniel Schramek 1,2,
PMCID: PMC10480194  PMID: 37670013

Correction to: Nature Communications 10.1038/s41467-023-38841-7, published online 31 May 2023

The original version of this Article contained an inaccuracy in the Methods section “CyTOF analysis”.

The original sentence “Cells were then washed twice by centrifuging through PBS (800 × g, 5′) prior to re-suspending in PBS with 4-element EQ normalization beads (Standard BioTools: 201078)” should have read “Cells were then washed twice by centrifuging through PBS at 800 × g, 5’ prior to re-suspending in Maxpar Cell Acquisition Solution (Standard BioTools: 201241) with 4-element EQ normalization beads (Standard BioTools: 201078)”.

This has now been corrected in the PDF and HTML versions of the Article.

Footnotes

The original article can be found online at 10.1038/s41467-023-38841-7.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES